| Reversal of warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non–small cell lung cancer V De Rosa, F Iommelli, M Monti, R Fonti, G Votta, MP Stoppelli, ... Clinical Cancer Research 21 (22), 5110-5120, 2015 | 148 | 2015 |
| Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention? S Bera, VD Rosa, W Rachidi, AM Diamond Mutagenesis 28 (2), 127-134, 2013 | 123 | 2013 |
| Protective effect of selenium supplementation on the genotoxicity of di (2-ethylhexyl) phthalate and mono (2-ethylhexyl) phthalate treatment in LNCaP cells P Erkekoğlu, W Rachidi, V De Rosa, B Giray, A Favier, F Hıncal Free Radical Biology and Medicine 49 (4), 559-566, 2010 | 88 | 2010 |
| Low doses of selenium specifically stimulate the repair of oxidative DNA damage in LNCaP prostate cancer cells V de Rosa, P Erkekoğlu, A Forestier, A Favier, F Hincal, AM Diamond, ... Free radical research 46 (2), 105-116, 2012 | 81 | 2012 |
| Neutrophil extracellular traps as an adhesion substrate for different tumor cells expressing RGD-binding integrins M Monti, V De Rosa, F Iommelli, MV Carriero, C Terlizzi, R Camerlingo, ... International Journal of Molecular Sciences 19 (8), 2350, 2018 | 69 | 2018 |
| Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells M Monti, F Iommelli, V De Rosa, MV Carriero, R Miceli, R Camerlingo, ... PloS one 12 (2), e0171362, 2017 | 61 | 2017 |
| Alzheimer’s disease-associated neurotoxic peptide amyloid-B impairs base excision repair in human neuroblastoma cells A Forestier, T Douki, S Sauvaigo, V De Rosa, C Demeilliers, W Rachidi International journal of molecular sciences 13 (11), 14766-14787, 2012 | 31 | 2012 |
| Coordinate modulation of glycolytic enzymes and OXPHOS by imatinib in BCR-ABL driven chronic myelogenous leukemia cells V De Rosa, M Monti, C Terlizzi, R Fonti, S Del Vecchio, F Iommelli International Journal of Molecular Sciences 20 (13), 3134, 2019 | 28 | 2019 |
| Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer Using 3′-Deoxy-3′-[18F]-Fluorothymidine … F Iommelli, V De Rosa, S Gargiulo, M Panico, M Monti, A Greco, ... Clinical Cancer Research 20 (18), 4806-4815, 2014 | 25 | 2014 |
| Inositol trisphosphate receptor type 3-mediated enhancement of EGFR and MET cotargeting efficacy in non–small cell lung cancer detected by 18F-fluorothymidine F Iommelli, V De Rosa, C Terlizzi, M Monti, M Panico, R Fonti, ... Clinical Cancer Research 24 (13), 3126-3136, 2018 | 22 | 2018 |
| Combination of Aβ secretion and oxidative stress in an Alzheimer-like cell line leads to the over-expression of the nucleotide excision repair proteins DDB2 and XPC A Forestier, T Douki, V De Rosa, D Béal, W Rachidi International Journal of Molecular Sciences 16 (8), 17422-17444, 2015 | 22 | 2015 |
| Non-Canonical Role of PDK1 as a Negative Regulator of Apoptosis through Macromolecular Complexes Assembly at the ER–Mitochondria Interface in Oncogene-Driven NSCLC V De Rosa, F Iommelli, C Terlizzi, E Leggiero, R Camerlingo, GG Altobelli, ... Cancers 13 (16), 4133, 2021 | 10 | 2021 |
| A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors F Iommelli, V De Rosa, C Terlizzi, R Fonti, R Camerlingo, MP Stoppelli, ... Cancers 13 (9), 2022, 2021 | 10 | 2021 |
| Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in non-small cell lung cancer treated with EGFR … V De Rosa, F Iommelli, M Monti, CG Mainolfi, R Fonti, S Del Vecchio EJNMMI research 6, 1-8, 2016 | 9 | 2016 |
| ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors C Terlizzi, V De Rosa, F Iommelli, A Pezone, GG Altobelli, M Maddalena, ... Cancer & Metabolism 11 (1), 20, 2023 | 8 | 2023 |
| ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC C De Rosa, V De Rosa, C Tuccillo, V Tirino, L Amato, F Papaccio, ... Scientific Reports 14 (1), 500, 2024 | 6 | 2024 |
| Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art HH Sheikhhossein, F Iommelli, N Di Pietro, MC Curia, A Piattelli, ... Vaccines 12 (5), 519, 2024 | 4 | 2024 |
| Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer F Iommelli, V De Rosa, R Fonti, S Del Vecchio Clinical and Translational Imaging 2, 43-53, 2014 | 4 | 2014 |
| PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer C De Rosa, F Iommelli, V De Rosa, G Ercolano, F Sodano, C Tuccillo, ... Biomedicines 12 (4), 809, 2024 | 2 | 2024 |
| Non-invasive detection of epithelial mesenchymal transition phenotype and metastatic dissemination of lung cancer by liquid biopsy V De Rosa, R Fonti, S Del Vecchio, F Iommelli Exploration of Targeted Anti-tumor Therapy 2 (1), 36, 2021 | 2 | 2021 |
